Alnylam Pharmaceuticals
ALNY
ALNY
304 hedge funds and large institutions have $7.94B invested in Alnylam Pharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 115 increasing their positions, 94 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
2% less funds holding
Funds holding: 309 → 304 (-5)
11% less first-time investments, than exits
New positions opened: 34 | Existing positions closed: 38
12% less capital invested
Capital invested by funds: $9B → $7.94B (-$1.06B)
Holders
304
Holding in Top 10
9
Calls
$139M
Puts
$105M
Top Buyers
| 1 | +$109M | |
| 2 | +$72.7M | |
| 3 | +$30.9M | |
| 4 |
Norges Bank
Oslo,
Norway
|
+$27.5M |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
+$24.3M |
Top Sellers
| 1 | -$125M | |
| 2 | -$88.7M | |
| 3 | -$69M | |
| 4 |
PA
Perceptive Advisors
New York
|
-$56.8M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$41.2M |